Literature DB >> 7715376

Management of chronic sinusitis in cystic fibrosis.

T M Davidson1, C Murphy, M Mitchell, C Smith, M Light.   

Abstract

Chronic rhinosinusitis is extremely common in patients with cystic fibrosis. It causes numerous problems in these patients and can put them at risk for life-threatening illness. Potential problems include nasal obstruction, congestion, sinus pain and pressure, infection (usually with Pseudomonas organisms), hyposmia or anosmia, and the seeding of bacteria into the lower respiratory tract. Cystic fibrosis patients with chronically infected sinuses are at increased risk for pneumonia following lung transplantation. A prophylactic protocol has been developed for the management of chronic sinusitis in patients with cystic fibrosis. These patients are fully evaluated at the Nasal Dysfunction Clinic of the University of California, San Diego (UCSD), Medical Center. Based on the results of the evaluation, they are treated with endoscopic sinus surgery, partial middle turbinectomy, septoplasty, and a large middle meatal maxillary antrostomy. Surgery is followed by a rigorous regimen of pulsatile hypotonic saline nasal irrigation to wash away tenacious cystic secretions. Tobramycin (Nebcin) is given once daily in the nasal irrigant to inhibit the growth of Pseudomonas organisms. At the USCD Nasal Dysfunction Clinic, this prepulmonary transplantation protocol is now used in all cystic fibrosis patients with chronic sinusitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7715376     DOI: 10.1288/00005537-199504000-00002

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  18 in total

Review 1.  Sinus disease in cystic fibrosis.

Authors:  G K Mak; N R Henig
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

Review 2.  Severe rhinosinusitis.

Authors:  Rosemary Hallett; Stanley M Naguwa
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 3.  Management of the upper airway in cystic fibrosis.

Authors:  Elisa A Illing; Bradford A Woodworth
Journal:  Curr Opin Pulm Med       Date:  2014-11       Impact factor: 3.155

Review 4.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

Review 5.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

6.  Outcomes of sinus surgery in adults with cystic fibrosis.

Authors:  Ayesha N Khalid; Jess Mace; Timothy L Smith
Journal:  Otolaryngol Head Neck Surg       Date:  2009-09       Impact factor: 3.497

7.  Outcomes of endoscopic sinus surgery in adult lung transplant patients with cystic fibrosis.

Authors:  Paolo Luparello; Maria S Lazio; Luca Voltolini; Beatrice Borchi; Giovanni Taccetti; Giandomenico Maggiore
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-01-28       Impact factor: 2.503

8.  Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.

Authors:  Kiranya E Tipirneni; Bradford A Woodworth
Journal:  Curr Otorhinolaryngol Rep       Date:  2017-02-21

Review 9.  Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis.

Authors:  M Boyd Gillespie; J David Osguthorpe
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

10.  Pseudomonas aeruginosa Acquisition in Cystic Fibrosis Patients in Context of Otorhinolaryngological Surgery or Dentist Attendance: Case Series and Discussion of Preventive Concepts.

Authors:  Jochen G Mainz; Andrea Gerber; Michael Lorenz; Ruth Michl; Julia Hentschel; Anika Nader; James F Beck; Mathias W Pletz; Andreas H Mueller
Journal:  Case Rep Infect Dis       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.